4-Oxo-1,4-dihydropyridine-2-carboxylic acid hydrobromide, 95+%, 5g

2-(4-Chlorophenoxy)-N,2-dimethyl-N-(2,3,4,5,6-pentahydroxyhexyl)propanamide, 250mg

5-Chloro-2-(methylthio)pyrimidine-4-carboxylic acid, 95.0%, 25g

(S)-methyl 5-((S)-1,1-dimethylethylsulfinamido)-5-(4-morpholinophenyl)-3-oxo-5-(thiophen-3-yl)pentanoate, 97%, 5mg

2-AZABICYCLO[2.2.2]OCTAN-5-ONE HCL, 95.0%, 250mg

Dichloromethane, min. 99.5%, for synthesis, 25 l, tinplate.

2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1,3,4-oxadiazole, 95.0%, 1g

(3R,4R)-3-((BENZO[D][1,3]DIOXOL-5-YLOXY)METHYL)-4-(4-FLUOROPHENYL)PIPERIDINE HCL, 95.0%, 1g

tert-Butyl 7-methyl-1,4-diazepane-1-carboxylate, 95.0%, 250mg

Fusaric acid, min. 99%, 250 mg, glass packaging

4-(4-BROMOPHENYL)THIOMORPHOLINE 1,1-DIOXIDE, 90.0%, 5g

2,3-Dihydro-2-(5-methyl-2-thienyl)-3-phenyl-4(1H)-quinazolinone, 250mg